EA201590745A1 - Твердая пероральная фармацевтическая композиция, содержащая тикагрелор - Google Patents

Твердая пероральная фармацевтическая композиция, содержащая тикагрелор

Info

Publication number
EA201590745A1
EA201590745A1 EA201590745A EA201590745A EA201590745A1 EA 201590745 A1 EA201590745 A1 EA 201590745A1 EA 201590745 A EA201590745 A EA 201590745A EA 201590745 A EA201590745 A EA 201590745A EA 201590745 A1 EA201590745 A1 EA 201590745A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
solid oral
oral pharmaceutical
composition containing
tikagrelor
Prior art date
Application number
EA201590745A
Other languages
English (en)
Russian (ru)
Inventor
Грегор Седмак
Original Assignee
Зентива, К.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива, К.С. filed Critical Зентива, К.С.
Publication of EA201590745A1 publication Critical patent/EA201590745A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
EA201590745A 2012-10-16 2013-10-15 Твердая пероральная фармацевтическая композиция, содержащая тикагрелор EA201590745A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2012-705A CZ2012705A3 (cs) 2012-10-16 2012-10-16 Pevná orální farmaceutická formulace obsahující ticagrelor
PCT/CZ2013/000130 WO2014059955A1 (en) 2012-10-16 2013-10-15 A solid oral pharmaceutical formulation containing ticagrelor

Publications (1)

Publication Number Publication Date
EA201590745A1 true EA201590745A1 (ru) 2015-08-31

Family

ID=49619770

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590745A EA201590745A1 (ru) 2012-10-16 2013-10-15 Твердая пероральная фармацевтическая композиция, содержащая тикагрелор

Country Status (13)

Country Link
EP (1) EP2908802A1 (ko)
JP (1) JP6301934B2 (ko)
KR (1) KR20150067153A (ko)
CN (1) CN104661649A (ko)
BR (1) BR112015008076A2 (ko)
CZ (1) CZ2012705A3 (ko)
EA (1) EA201590745A1 (ko)
HK (1) HK1205456A1 (ko)
IL (1) IL238036B (ko)
MX (1) MX2015003866A (ko)
UA (1) UA116784C2 (ko)
WO (1) WO2014059955A1 (ko)
ZA (1) ZA201501954B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160012706A (ko) * 2014-07-25 2016-02-03 동아에스티 주식회사 서방성 제제
CN111588702B (zh) * 2015-04-29 2023-01-20 江苏恒瑞医药股份有限公司 一种替格瑞洛或其可药用盐的制剂
CN105193759B (zh) * 2015-09-18 2018-07-03 乐普药业股份有限公司 一种替格瑞洛片及其制备方法
CN106667926B (zh) * 2015-11-09 2020-01-17 石药集团中奇制药技术（石家庄）有限公司 一种法匹拉韦片剂及其制备方法
TR201601835A2 (tr) * 2016-02-12 2017-08-21 Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi Ti̇kagrelor i̇çeren formülasyonlar i̇çi̇n üreti̇m yöntemi̇
IL262312B (en) * 2016-04-21 2022-08-01 Astrazeneca Ab Tablets containing ticagrelor that disintegrate upon oral administration and a process for their preparation
TR201617983A2 (tr) * 2016-12-07 2018-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Ti̇cagrelorun kati oral farmasöti̇k bi̇leşi̇mleri̇
KR102610876B1 (ko) * 2018-03-05 2023-12-06 주식회사 파마코스텍 티카그렐러 푸마르산 i형 결정 및 그 제조방법
WO2019170244A1 (en) 2018-03-08 2019-09-12 Pharmaceutical Oriented Services Ltd. Ticagrelor—containing tablet formulation
WO2020021110A1 (en) 2018-07-27 2020-01-30 Krka, D.D., Novo Mesto Pharmaceutical composition of ticagrelor
CN111450067A (zh) * 2019-01-18 2020-07-28 北京万全德众医药生物技术有限公司 一种替格瑞洛分散片及其制备方法
CN116370423A (zh) * 2023-02-28 2023-07-04 天津力生制药股份有限公司 一种替格瑞洛口腔崩解片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
JPH11199517A (ja) * 1997-10-31 1999-07-27 Meiji Seika Kaisha Ltd 口腔内速崩壊性錠剤
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
WO2007018057A1 (ja) * 2005-08-05 2007-02-15 Freund Corporation 口腔内速崩壊錠およびその製造法
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
WO2008024044A1 (en) 2006-08-21 2008-02-28 Astrazeneca Ab Compositions, suitable for oral administration, comprising a triazolo [4, 5] pyrimidin derivate
CA2781182A1 (en) 2009-12-03 2011-06-09 Astrazeneca Ab Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
EP2515871B1 (en) * 2009-12-23 2015-09-23 ratiopharm GmbH Solid pharmaceutical dosage form of ticagrelor

Also Published As

Publication number Publication date
IL238036A0 (en) 2015-05-31
JP6301934B2 (ja) 2018-03-28
CN104661649A (zh) 2015-05-27
WO2014059955A1 (en) 2014-04-24
CZ2012705A3 (cs) 2014-04-23
KR20150067153A (ko) 2015-06-17
MX2015003866A (es) 2015-07-17
ZA201501954B (en) 2017-04-26
UA116784C2 (uk) 2018-05-10
BR112015008076A2 (pt) 2017-07-04
HK1205456A1 (en) 2015-12-18
JP2015533129A (ja) 2015-11-19
EP2908802A1 (en) 2015-08-26
IL238036B (en) 2019-05-30

Similar Documents

Publication Publication Date Title
EA201590745A1 (ru) Твердая пероральная фармацевтическая композиция, содержащая тикагрелор
WO2012065022A3 (en) Spiro-oxindole mdm2 antagonists
MX346375B (es) Antagonistas de espiro-oxindol de mdm2.
IL244206A0 (en) A pharmaceutical preparation containing a pyrimidine compound as an active ingredient
DOP2016000327A (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13,13a-octahidro-2,5-metanopirido[1’,2’:4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
PE20150332A1 (es) Imidazotriazincarbonitrilos utiles como inhibidores de cinasa
EA201690357A1 (ru) Лекарственные формы с замедленным высвобождением для ингибитора jak1
EA201892150A1 (ru) Распадающиеся в полости рта таблетки
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
AP2014007880A0 (en) Amidine substituted beta-lactam compounds, their preparation and use as antibacterial agents
UY34191A (es) ?N-(6-((2R,3S)-3,4-Dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pirimidin-4-il)-3-metilazetidina-1-sulfonamida y sales farmacéuticamente aceptables de lamisma?.
EA201790939A1 (ru) ТРИАЗОЛО[4,5-d]ПИРИМИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ КАННАБИНОИДНЫХ РЕЦЕПТОРОВ ТИПА 2
AR093527A1 (es) 6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8
CL2015001730A1 (es) Compuestos triciclos inhibidores del canal cftr; composicion y combinacion farmaceutica; y uso en el tratamiento de la enfermedad renal poliquistica y diarrea.
EA024825B8 (ru) Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение
HK1206337A1 (en) Crystalline forms of (s)-4-aminon-(1-(4-chlorophenyl)-3- hydroxypropyl)-1-(7h -pyrrolo[2, 3-d]pyrimidi n-4-yl) piperidine-4- carboxamide (s)-4--n-(1-(4-)-3-)-1-(7h-[23-d]-4-) -4-
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
IN2014MN01382A (ko)
IL228589B (en) Pyrimidine-4 [d-3,2] pyrrolo-h7)-1-(yl)-3-hydroxypropyl -4 chloro)-1)-n- and -4-ami (s)yl)piperidine-4 - Carboxamide or its acceptable pharmaceutical salt for use in cancer treatment
MA35943B1 (fr) Utilisation de (rs)-s-cyclopropyl-s-(4-{[4-{ [(1r, 2r)-2-hydroxy-1-méthylpropyl]oxy}-5-(trifluorméthyl) pyrimidin-2-yl]amino}
NZ705994A (en) Process for preparing pemetrexed di potassium and its hydrates
MY194359A (en) Orally disintegrating tablets
TN2013000202A1 (en) Spiro-oxindole mdm2 antagonists
HK1209642A1 (en) Anti-tumoral composition comprising the compound 1-(6-[6-(4- fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl-1,3- benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea 1-(6-[6-(4-)[124][43-b]-3-]-13- -2-)-3-(2--4-)